**Question:** Bradykinin is for

A. Vasodilation
B. Inflammation
C. Vasoconstriction
D. Analgesia

**Core Concept:**
Bradykinin is a potent vasodilator and a potent non-peptide agonist of the B2-receptor, which is widely distributed in the cardiovascular, respiratory, and renal systems. It is a bioactive peptide derived from the proteolytic cleavage of high-molecular-weight kininogens by kininogens.

**Why the Correct Answer is Right:**
Bradykinin promotes vasodilation by activating the B2-receptor, leading to the release of nitric oxide (NO) and prostaglandins. These substances cause smooth muscle relaxation in blood vessels, leading to increased blood flow and decreased vascular resistance. This action contributes to the cardiovascular effects of Bradykinin.

**Why Each Wrong Option is Incorrect:**
A. Vasoconstriction (Option C) is the opposite of vasodilation. Bradykinin does not cause vasoconstriction but vasodilation, making Option C incorrect.
B. Inflammation (Option B) is a physiological response, not a direct effect of Bradykinin. Bradykinin modulates inflammation through other mechanisms, but not as a primary action.
D. Analgesia (Option D) refers to pain relief, which is not the primary function of Bradykinin. Bradykinin primarily affects blood vessels and other vascular beds, not pain modulation.

**Clinical Pearl:**
Bradykinin is involved in a wide range of physiological processes, including the regulation of blood pressure, hypotension during hemorrhage, and the mediation of the hypotensive response to tissue injury. However, its primary function remains as a potent vasodilator and a modulator of inflammation.